Anpario (LON:ANP – Get Free Report) issued its quarterly earnings results on Monday. The company reported GBX 28.40 ($0.37) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Anpario had a return on equity of 8.74% and a net margin of 9.23%.
Anpario Stock Performance
ANP stock opened at GBX 380 ($4.91) on Wednesday. The company has a 50 day moving average price of GBX 432.58 and a 200 day moving average price of GBX 377.46. Anpario has a fifty-two week low of GBX 229.50 ($2.97) and a fifty-two week high of GBX 488.55 ($6.32). The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16. The stock has a market capitalization of £64.83 million, a PE ratio of 20.98 and a beta of 0.58.
Anpario Increases Dividend
The business also recently declared a dividend, which will be paid on Friday, July 25th. Investors of record on Thursday, July 10th will be issued a GBX 8 ($0.10) dividend. The ex-dividend date of this dividend is Thursday, July 10th. This represents a dividend yield of 2.09%. This is a positive change from Anpario’s previous dividend of $3.25. Anpario’s dividend payout ratio (DPR) is currently 60.74%.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on ANP
Insider Buying and Selling at Anpario
In related news, insider Marc Wilson acquired 3,778 shares of the firm’s stock in a transaction that occurred on Tuesday, April 1st. The stock was acquired at an average cost of GBX 398 ($5.15) per share, with a total value of £15,036.44 ($19,439.48). Corporate insiders own 30.51% of the company’s stock.
About Anpario
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
See Also
- Five stocks we like better than Anpario
- 3 Healthcare Dividend Stocks to Buy
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- The 3 Most Talked About Investments on WallStreetBets Right Now
- Why Are These Companies Considered Blue Chips?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.